The Brazilian Journal of Infectious Diseases · 2006 · 22 citations · 10 references
PharmacyPharmacologyPharmacotherapyHepatitis PharmacotherapyPsychiatric PharmacotherapyPsychopharmacologyAntiviral PharmacologyAntiviral TherapyInterferon-based TherapyMental IllnessViral HepatitisViral Hepatitis TreatmentHepatitis C Virus ManagementInterferon Alfa TherapyInterferon Alpha-2b TherapyMajor DepressionPegylated Interferon AlfaPsychosis PharmacotherapyRibavirin TherapyRibavirin-based Regimens
Pegylated Interferon-alpha, combined with ribavirin, gives high sustained virological response in patients with hepatitis C virus, an important public health problem and one of the most frequent chronic infectious diseases worldwide. Though it has therapeutic benefits, treatment with IFN-alpha may be complicated by various side effects, especially symptoms of major depression and acute mania. Psychosis is a rare side effect, and its management usually includes discontinuation of IFN-alpha. We report a case of psychotic disorder that occurred during therapy with pegylated Interferon-alpha given associated with ribavirin. After good response to psychiatric treatment, it became possible to finish the anti-viral therapy.
10
Lee M. Zuckerman, Moshe Rehavi, Rachel Nachman et al. · Neuropsychopharmacology · 2003 · 486 citations
M. Koffler · The Lancet · 1965 · 434 citations